Light chain deposition disease involving kidney and liver in a patient with IgD myeloma
Abstract Background IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported. We report herein the details of the first reported case of LCDD involving the kidney and liver co-occurring with IgD myelo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12882-021-02246-9 |
_version_ | 1818563786159685632 |
---|---|
author | Takafumi Tsushima Tomo Suzuki Toshiki Terao Daisuke Miura Kentaro Narita Masami Takeuchi Akira Shimuzu Kosei Matsue |
author_facet | Takafumi Tsushima Tomo Suzuki Toshiki Terao Daisuke Miura Kentaro Narita Masami Takeuchi Akira Shimuzu Kosei Matsue |
author_sort | Takafumi Tsushima |
collection | DOAJ |
description | Abstract Background IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported. We report herein the details of the first reported case of LCDD involving the kidney and liver co-occurring with IgD myeloma. Case presentation A 66-year-old female with IgD MM presented with rapidly progressive acute renal failure, ascites and pleural effusion. Immunofluorescent study of revealed the characteristic linear deposition of Igκ light chain along the glomerular and tubular basement membrane in kidney. Electron microscopy showed the powdery electron-dense deposits along the tubular and glomerular basement membrane consistent with the diagnosis of LCDD. Laser microdissection followed by mass spectrometry identified only Igκ light chain with more than 95% probability confirm the diagnosis of κ-LCDD but not heavy/light chain deposition disease. Liver biopsy with immunofluorescence study revealed the linear deposition of Igκ chain along the perisinusoidal space indicating the hepatic involvement of κ-LCDD. The patient was successfully treated with combination therapy with bortezomib, cyclophosphamide, dexamethasone, and daratumumab. Conclusions This report emphasizes that prompt biopsy of affected organs and initiation of clone directed therapy led to the correct diagnosis and favorable outcome in patient with LCDD who has extrarenal involvement. |
first_indexed | 2024-12-14T01:20:55Z |
format | Article |
id | doaj.art-d2b8e1a46b9b4301a2386008863cc359 |
institution | Directory Open Access Journal |
issn | 1471-2369 |
language | English |
last_indexed | 2024-12-14T01:20:55Z |
publishDate | 2021-01-01 |
publisher | BMC |
record_format | Article |
series | BMC Nephrology |
spelling | doaj.art-d2b8e1a46b9b4301a2386008863cc3592022-12-21T23:22:24ZengBMCBMC Nephrology1471-23692021-01-012211610.1186/s12882-021-02246-9Light chain deposition disease involving kidney and liver in a patient with IgD myelomaTakafumi Tsushima0Tomo Suzuki1Toshiki Terao2Daisuke Miura3Kentaro Narita4Masami Takeuchi5Akira Shimuzu6Kosei Matsue7Division of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Nephrology, Department of Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterDepartment of Analytic Human Pathology, Nippon Medical SchoolDivision of Hematology/Oncology, Department of Internal Medicine, Kameda Medical CenterAbstract Background IgD multiple myeloma (MM) is a rare subtype of MM and light chain deposition disease (LCDD) outside the kidney is also a rare and has scarcely been reported. We report herein the details of the first reported case of LCDD involving the kidney and liver co-occurring with IgD myeloma. Case presentation A 66-year-old female with IgD MM presented with rapidly progressive acute renal failure, ascites and pleural effusion. Immunofluorescent study of revealed the characteristic linear deposition of Igκ light chain along the glomerular and tubular basement membrane in kidney. Electron microscopy showed the powdery electron-dense deposits along the tubular and glomerular basement membrane consistent with the diagnosis of LCDD. Laser microdissection followed by mass spectrometry identified only Igκ light chain with more than 95% probability confirm the diagnosis of κ-LCDD but not heavy/light chain deposition disease. Liver biopsy with immunofluorescence study revealed the linear deposition of Igκ chain along the perisinusoidal space indicating the hepatic involvement of κ-LCDD. The patient was successfully treated with combination therapy with bortezomib, cyclophosphamide, dexamethasone, and daratumumab. Conclusions This report emphasizes that prompt biopsy of affected organs and initiation of clone directed therapy led to the correct diagnosis and favorable outcome in patient with LCDD who has extrarenal involvement.https://doi.org/10.1186/s12882-021-02246-9IgD myelomaLight chain deposition diseaseLiver involvementDaratumumabCyBorD |
spellingShingle | Takafumi Tsushima Tomo Suzuki Toshiki Terao Daisuke Miura Kentaro Narita Masami Takeuchi Akira Shimuzu Kosei Matsue Light chain deposition disease involving kidney and liver in a patient with IgD myeloma BMC Nephrology IgD myeloma Light chain deposition disease Liver involvement Daratumumab CyBorD |
title | Light chain deposition disease involving kidney and liver in a patient with IgD myeloma |
title_full | Light chain deposition disease involving kidney and liver in a patient with IgD myeloma |
title_fullStr | Light chain deposition disease involving kidney and liver in a patient with IgD myeloma |
title_full_unstemmed | Light chain deposition disease involving kidney and liver in a patient with IgD myeloma |
title_short | Light chain deposition disease involving kidney and liver in a patient with IgD myeloma |
title_sort | light chain deposition disease involving kidney and liver in a patient with igd myeloma |
topic | IgD myeloma Light chain deposition disease Liver involvement Daratumumab CyBorD |
url | https://doi.org/10.1186/s12882-021-02246-9 |
work_keys_str_mv | AT takafumitsushima lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma AT tomosuzuki lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma AT toshikiterao lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma AT daisukemiura lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma AT kentaronarita lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma AT masamitakeuchi lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma AT akirashimuzu lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma AT koseimatsue lightchaindepositiondiseaseinvolvingkidneyandliverinapatientwithigdmyeloma |